Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Plos Neglected Tropical Diseases|January 20, 2017
The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical DiseasesWilliam K Redekop, Edeltraud J Lenk, Marianne Luyendijk, et al.Journal of the National Cancer Institute|January 11, 2025
Disparities in cervical cancer elimination timeframes in the United States: a comparative modeling studyEmily A Burger, Erik E L Jansen, Daniël de Bondt, et al.Plos Medicine|February 22, 2017
Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraintsEvelinn Mikkelsen, Jan A C Hontelez, Maarten P M Jansen, et al.Plos Neglected Tropical Diseases|March 14, 2018
Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas diseaseEdeltraud J Lenk, William K Redekop, Marianne Luyendijk, et al.Plos Medicine|July 18, 2012
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South AfricaJeffrey W Eaton, Leigh F Johnson, Joshua A Salomon, et al.Plos Neglected Tropical Diseases|February 19, 2016
Concerted Efforts to Control or Eliminate Neglected Tropical Diseases: How Much Health Will Be Gained?Sake J de Vlas, Wilma A Stolk, Epke A le Rutte, et al.Eclinicalmedicine|July 8, 2025
The impact of the PEPFAR funding freeze on HIV deaths and infections: a mathematical modelling study of seven countries in sub-Saharan AfricaJan A C Hontelez, Hannah Goymann, Yemane Berhane, et al.The Lancet. Public Health|December 19, 2017
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic modelsMarc Brisson, Élodie Bénard, Mélanie Drolet, et al.The Lancet. Global Health|August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.The Lancet. Global Health|August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.Pageof 5